arginyl-glycyl-aspartic acid has been researched along with Cells, Neoplasm Circulating in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, YJ; Gong, YK; Li, N; Li, T; Ma, Y; Xing, CM | 1 |
| Duffin, TD; Griggs, DW; Keene, JL; Nickols, MA; Ruminski, PG; Schroeter, S; Settle, SL; Shannon, KE; Westlin, M | 1 |
| Donati, MB; Poggi, A; Stella, M | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
The importance of blood cell-vessel wall interactions in tumour metastasis.
Topics: Amino Acid Sequence; Animals; Blood Cells; Blood Platelets; Blood Proteins; Cell Adhesion; Cytokines; Cytoplasmic Granules; Disintegrins; Endothelium, Vascular; Extracellular Matrix; Fatty Acids; Growth Substances; Humans; Immunotherapy; Leukocytes; Macrophages; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Proteins; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Oligopeptides; Peptides; Platelet Activation; Platelet Aggregation Inhibitors | 1993 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
A blood cell repelling and tumor cell capturing surface for high-purity enrichment of circulating tumor cells.
Topics: Blood Cells; Cell Adhesion; Cell Separation; Cell Survival; Folic Acid; HeLa Cells; Humans; Liquid Biopsy; MCF-7 Cells; Microfluidic Analytical Techniques; Neoplasms; Neoplastic Cells, Circulating; Oligopeptides; Polyethylene Glycols | 2019 |
Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal; Cell Division; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Dipeptides; Drug Administration Schedule; Endothelial Cells; Endothelium, Vascular; Female; Humans; Infusion Pumps, Implantable; Integrin alphaVbeta3; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Proteins; Neoplastic Cells, Circulating; Oligopeptides; Organic Chemicals; Pyrimidines; Xenograft Model Antitumor Assays | 2004 |